Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

1.56%

97.5¢ mesoblast limited

Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-280

First 280 Last

Share
Profile

Follow
ddwn

12,468 Posts.

3377

15/12/20

11:18

Post #: 49584592
Share

Originally posted by TehBlaster: ↑

When asked about a potential further trial, Silvo states;

"Our discussions with the FDA have been, potentially meeting a mortality reduction outcome will suffice for a single trial approval in that patient population with a high mortality risk. Whilst mortality was a secondary end point and not a primary, achieving it in this order of magnitude is a very important observation that i think we will be sitting down with the FDA in close order.

Hospitalization, traditionally have been considered to be surrogate to primary end point as drugs that have been approved for Heart Failure have not been able to achieve Mortality outcomes.

I think our study suggests even more than that, It raises the possibility that heart failure hospitalisations may not even be appropriate surrogates for mortality since we've had such a strong mortality affect and i think that is what i mean when i say that this will potentially change the paradigm of how heart failure should be considered in terms of its treatment characteristics."

BULLISH!!

Expand

How can this be read as anything other than positive - yet, the market is having a real crack at pushing down the SP - go figure!

MSB Price at posting: $3.97 Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

WHC

Whitehaven to sell 30% of Blackwater coal mine to Japanese JV partners

STK

Strickland Metals jumps on mammoth gold-copper-silver hit over 300m width at Serbian Rogozna Project

The Rising Tide: How institutional adoption is shaping the future of crypto

OSX

Osteopore winds up 3D printed bone implant study bankrolled by the Chilean Government

There are more pages in this discussion • 743 more messages in this thread...

First 280 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 97.5¢		Change 0.015(1.56%)		Mkt cap ! $1.118B

Open	High	Low	Value	Volume
97.0¢	99.5¢	97.0¢	$941.2K	958.9K

Buyers (Bids)

No.	Vol.	Price($)
6	21709	97.5¢

Sellers (Offers)

Price($)	Vol.	No.
98.0¢	61668	23

View Market Depth

No.	Vol.	Price($)
11	69335	0.975
15	158144	0.970
12	334793	0.965
10	559629	0.960
3	26200	0.955

Price($)	Vol.	No.
0.985	51432	22
0.990	118831	15
0.995	135315	15
1.000	99317	9
1.005	24581	2

Last trade - 10.53am 22/08/2024 (20 minute delay)

MSB (ASX) Chart